Rosetta Genomics to Study MicroRNAs in HIV Infections for NIH | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics will work with the National Institutes of Health to discover microRNAs that may be involved in the viral replication of HIV, the company said today.

Rosetta said it will tap into its microRNA intellectual property and technologies, as well as publicly known human and viral microRNAs, to find out how microRNAs are involved in viral replication in HIV infections and the life cycle of the disease, and whether they may be used as potential novel drug targets for the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.